<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04950855</url>
  </required_header>
  <id_info>
    <org_study_id>Study1</org_study_id>
    <nct_id>NCT04950855</nct_id>
  </id_info>
  <brief_title>Retinal and Choroidal Microvascular Changes During Pregnancy Period Detected With Optical Coherence Tomography Angiography</brief_title>
  <official_title>Evaluation of Retinal and Choroidal Microvascular Structures: Comparison With Three Trimesters of Healthy Pregnant Women and Healthy Non-pregnant Women Using Optical Coherence Tomography Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akdeniz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akdeniz University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During pregnancy many physiological changes and adaptations occur.Hormonal, hematological and&#xD;
      hemodynamic changes are responsible for most of the ocular adaptations.We are planning to&#xD;
      compare the choroid and retinal blood flow values and choroidal thickness of pregnant women&#xD;
      and healthy non pregnant women with optical coherence tomography and optic coherence&#xD;
      tomography angiography&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During pregnancy many physiological changes and adaptations occur such as pulmonary, renal,&#xD;
      endocrinological, haematological and visual system changes are happening. In previous&#xD;
      studies, retinal and choroidal pregnancy-related changes in blood flow and choroidal&#xD;
      thickness have been demonstrated. Optical coherence tomography angiography (OCTA) detects the&#xD;
      contrast of motion in the blood flow, detecting the capillary of the retina and choroid.&#xD;
&#xD;
      It is a new functional method that visualizes the retinal networks and outer retina without&#xD;
      using dyes.It is a non-invasive method that provides volumetric angiography information. In&#xD;
      this study evaluation of the variability of choroidal and retinal blood flow changes and&#xD;
      choroidal thickness, between trimesters of pregnancy and the non-pregnant control group is&#xD;
      planned. Choroid and Retinal Blood Flow Values and Choroidal thickness in 41 pregnant women&#xD;
      in the first trimester and it would be repeated at second and third trimesters. We compare&#xD;
      measured values between trimesters and 45 healthy non-pregnant women.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to the difficulty in following pregnant women due to the covid 19 pandemic&#xD;
  </why_stopped>
  <start_date type="Actual">June 26, 2021</start_date>
  <completion_date type="Actual">November 1, 2021</completion_date>
  <primary_completion_date type="Actual">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Choroidal thickness</measure>
    <time_frame>40 weeks</time_frame>
    <description>Choroidal thickness is measured by optical coherence tomography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retinal thickness</measure>
    <time_frame>40 weeks</time_frame>
    <description>Retinal thickness is measured by optical coherence tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Foveal avascular zone(FAZ) area measurement</measure>
    <time_frame>40 weeks</time_frame>
    <description>FAZ area is measured by optical coherence tomography anjiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal vascular density</measure>
    <time_frame>40 weeks</time_frame>
    <description>% of retinal vascular density is measured by optical coherence tomography angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal nerve fiber layer thickness</measure>
    <time_frame>40 weeks</time_frame>
    <description>Retinal nerve fiber layer thickness (um) is measured by optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ganglion cell layer measurement</measure>
    <time_frame>40 weeks</time_frame>
    <description>Ganglion cell layer measurement is measured by optical coherence tomography</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">86</enrollment>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Pregnant Women</arm_group_label>
    <description>Healty pregnant women between 18-45 years,with no history of eye surgery and systemical disease.In 1st , 2nd and 3rd trimesters the measurements will be repeated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Healty non-pregnant women between 18-45 years with no history of eye surgery and systemical disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Optical Coherence Tomography,Optical Coherence Tomography Angiography(Topcon)</intervention_name>
    <description>Optical coherence tomography optical coherence tomography angiography</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Pregnant Women</arm_group_label>
    <other_name>Pachymetry</other_name>
    <other_name>Otorefractometry</other_name>
    <other_name>Tonometry</other_name>
    <other_name>Blood Pressure Measurement</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Retinal and choroid thickness and retinal angiographic values will be measured in healthy&#xD;
        pregnant population (1 time for each trimester,totally 3 times) and healty control group&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy pregnant women Age &gt; 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemical disease such as diabetes mellitus or hypertension&#xD;
&#xD;
          -  Refractive error; spherical equivalence &gt; 4 diopters&#xD;
&#xD;
          -  Ocular disease or surgery history&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Akdeniz University Hospital</name>
      <address>
        <city>Antalya</city>
        <zip>07070</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 24, 2021</study_first_submitted>
  <study_first_submitted_qc>June 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Akdeniz University</investigator_affiliation>
    <investigator_full_name>Ã‡isil Erkan Pota</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Tomography, Optical Coherence</keyword>
  <keyword>Choroid</keyword>
  <keyword>retina</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

